Search Results - "Szeto, Livia" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Paxillin Is a Target for Somatic Mutations in Lung Cancer : Implications for Cell Growth and Invasion

Paxillin Is a Target for Somatic Mutations in Lung Cancer : Implications for Cell Growth and Invasion

by JAGADEESWARAN, Ramasamy, SURAWSKA, Hanna, SCHWARTZ, Stuart, FAORO, Leonardo, WANG, Yi-Ching, GIRARD, Luc, TRETIAKOVA, Maria S, AHMED, Salman, ZUMBA, Osvaldo, SOULII, Lioubov, BINDOKAS, Vytas P, SZETO, Livia L, KRISHNASWAMY, Soundararajan, GORDON, Gavin J, BUENO, Raphael, SUGARBAKER, David, LINGEN, Mark W, SATTLER, Martin, KRAUSZ, Thomas, VIGNESWARAN, Wickii, NATARAJAN, Viswanathan, MINNA, John, VOKES, Everett E, JANAMANCHI, Varalakshmi, FERGUSON, Mark K, HUSAIN, Aliya N, SALGIA, Ravi, MACKINNON, A. Craig, SEIWERT, Tanguy Y, LOGANATHAN, Sivakumar, KANTETI, Rajani, REICHMAN, Trevor, NALLASURA, Vidya
Published in Cancer research (Chicago, Ill.) (2008)

Get full text

Journal Article

Phase I Study of G3139, a bcl-2 Antisense Oligonucleotide, Combined With Carboplatin and Etoposide in Patients With Small-Cell Lung Cancer

Phase I Study of G3139, a bcl-2 Antisense Oligonucleotide, Combined With Carboplatin and Etoposide in Patients With Small-Cell Lung Cancer

by RUDIN, Charles M, KOZLOFF, Mark, HOFFMAN, Philip C, EDELMAN, Martin J, KARNAUSKAS, Robyn, TOMEK, Ronald, SZETO, Livia, VOKES, Everett E
Published in Journal of clinical oncology (15.03.2004)

Get full text

Journal Article

A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer

A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer

by SEIWERT, Tanguy Y, CONNELL, Philip P, VOKES, Everett E, MAUER, Ann M, HOFFMAN, Philip C, GEORGE, Christopher M, SZETO, Livia, SALGIA, Ravi, POSTHER, Katherine E, NGUYEN, Binh, HARAF, Daniel J
Published in Clinical cancer research (15.01.2007)

Get full text

Journal Article

Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction

Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction

by Choong, Nicholas W., Mauer, Ann M., Haraf, Daniel C., Ferguson, Mark K., Sandler, Alan B., Kesler, Kenneth A., Fishkin, Paul A. S., Ansari, Rafat H., Wade, James, Krauss, Stuart A., Sciortino, David F., Posner, Mitchell C., Kocherginsky, Masha, Hoffman, Philip C., Szeto, Livia, Vokes, Everett E.
Published in Medical oncology (Northwood, London, England) (01.12.2011)

Get full text

Journal Article

Sustained oligoclonal T cell expansion correlates with durable response to anti-PD1 therapy

Sustained oligoclonal T cell expansion correlates with durable response to anti-PD1 therapy

by Olugbile, Sope Omowale, Kiyotani, Kazuma, Park, Jae Hyun, Hoffman, Philip C., Szeto, Livia, Patel, Jyoti D., Vokes, Everett E., Nakamura, Yusuke
Published in Journal of clinical oncology (20.05.2017)

Get full text

Journal Article

P3.02c-058 In-Depth Molecular Characterization of T Cell Clonal Expansion Induced by Anti-PD1 Therapy in NSCLC: Topic: IT Biomarkers

P3.02c-058 In-Depth Molecular Characterization of T Cell Clonal Expansion Induced by Anti-PD1 Therapy in NSCLC: Topic: IT Biomarkers

by Olugbile, Sope, Kiyotani, Kazuma, Inoue, Hiroyuki, Park, Jae-Hyun, Hoffman, Phillip, Szeto, Livia, Patel, Jyoti, Vokes, Everett, Nakamura, Yusuke
Published in Journal of thoracic oncology (01.01.2017)

Get full text

Journal Article

P3.02c-058 In-Depth Molecular Characterization of T Cell Clonal Expansion Induced by Anti-PD1 Therapy in NSCLC

P3.02c-058 In-Depth Molecular Characterization of T Cell Clonal Expansion Induced by Anti-PD1 Therapy in NSCLC

by Olugbile, Sope, Kiyotani, Kazuma, Inoue, Hiroyuki, Park, Jae-Hyun, Hoffman, Phillip, Szeto, Livia, Patel, Jyoti, Vokes, Everett, Nakamura, Yusuke
Published in Journal of thoracic oncology (01.01.2017)

Get full text

Journal Article

PS01.05: Early and Persistent Oligoclonal T Cell Expansion Correlates with Durable Response to Anti-PD1 Therapy in NSCLC

PS01.05: Early and Persistent Oligoclonal T Cell Expansion Correlates with Durable Response to Anti-PD1 Therapy in NSCLC

by Olugbile, Sope, Kiyotani, Kazuma, Park, Jae-Hyun, Hoffman, Philip, Szeto, Livia, Patel, Jyoti, Vokes, Everett, Nakamura, Yusuke
Published in Journal of thoracic oncology (01.11.2016)

Get full text

Journal Article

PS01.05: Early and Persistent Oligoclonal T Cell Expansion Correlates with Durable Response to Anti-PD1 Therapy in NSCLC: Topic: Medical Oncology

PS01.05: Early and Persistent Oligoclonal T Cell Expansion Correlates with Durable Response to Anti-PD1 Therapy in NSCLC: Topic: Medical Oncology

by Olugbile, Sope, Kiyotani, Kazuma, Park, Jae-Hyun, Hoffman, Philip, Szeto, Livia, Patel, Jyoti, Vokes, Everett, Nakamura, Yusuke
Published in Journal of thoracic oncology (01.11.2016)

Get full text

Journal Article

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

by Choong, Nicholas W., Mauer, Ann M., Haraf, Daniel J., Lester, Eric, Hoffman, Philip C., Kozloff, Mark, Lin, Shang, Dancey, Janet E., Szeto, Livia, Grushko, Tatyana, Olopade, Olufunmilayo I., Salgia, Ravi, Vokes, Everett E.
Published in Journal of thoracic oncology (01.09.2008)

Get full text

Journal Article

Sustained Oligoclonal T Cell Expansion Correlates with Durable Response to Immune Checkpoint Blockade in Lung Cancer

Sustained Oligoclonal T Cell Expansion Correlates with Durable Response to Immune Checkpoint Blockade in Lung Cancer

by Olugbile, Sope, Park, Jae Hyun, Hoffman, Philip, Szeto, Livia, Patel, Jyoti, Vigneswaran, Wickii T, Vokes, Everett, Nakamura, Yusuke, Kiyotani, Kazuma
Published in Journal of cancer science & therapy (2017)

Get full text

Journal Article

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

by Maitland, Michael L, Levine, Matthew R, Lacouture, Mario E, Wroblewski, Kristen E, Chung, Christine H, Gordon, Ilyssa O, Szeto, Livia, Ratko, Gail, Soltani, Keyoumars, Kozloff, Mark F, Hoffman, Philip C, Salgia, Ravi, Carbone, David P, Karrison, Theodore G, Vokes, Everett E
Published in BMC cancer (04.01.2014)

Get full text

Journal Article

Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non–Small-Cell Lung Cancer, A Phase II Trial

Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non–Small-Cell Lung Cancer, A Phase II Trial

by Cohen, Ezra E.W, Subramanian, Janakiraman, Gao, Feng, Szeto, Livia, Kozloff, Mark, Faoro, Leonardo, Karrison, Theodore, Salgia, Ravi, Govindan, Ramaswamy, Vokes, Everett E
Published in Clinical lung cancer (01.03.2012)

Get full text

Journal Article

C3-01: Phase I Trial of Erlotinib-based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

C3-01: Phase I Trial of Erlotinib-based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

by Choong, Nicholas W., Mauer, Ann M., Lester, Eric, Hoffman, Philip C., Haraf, Daniel, Kozloff, Mark, Szeto, Livia, Vokes, Everett E.
Published in Journal of thoracic oncology (01.08.2007)

Get full text

Journal Article

P3-087: Phase II trial of sequenced bevacizumab and erlotinib with bevacizumab and chemotherapy for 1st line stage IIIB or IV Non-small cell lung cancer (NSCLC)

P3-087: Phase II trial of sequenced bevacizumab and erlotinib with bevacizumab and chemotherapy for 1st line stage IIIB or IV Non-small cell lung cancer (NSCLC)

by Govindan, Ramaswamy, Cohen, Ezra E., Kozloff, Mark F., Mauer, Ann M., Hoffman, Philip C., Karrison, Theodore, Schwegman, Julie, Szeto, Livia, Salgia, Ravi, Vokes, Everett E.
Published in Journal of thoracic oncology (01.08.2007)

Get full text

Journal Article

Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer

Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer

by Choong, Nicholas W., Vokes, Everett E., Haraf, Daniel J., Tothy, Peter K., Ferguson, Mark K., Kasza, Kristen, Rudin, Charles M., Hoffman, Philip C., Krauss, Stuart A., Szeto, Livia, Mauer, Ann M.
Published in Journal of thoracic oncology (01.01.2008)

Get full text

Journal Article

Phase II Trial of Temozolomide and Irinotecan as Second-Line Treatment for Advanced Non–small Cell Lung Cancer

Phase II Trial of Temozolomide and Irinotecan as Second-Line Treatment for Advanced Non–small Cell Lung Cancer

by Choong, Nicholas W., Mauer, Ann M., Hoffman, Philip C., Rudin, Charles M., Winegarden, Jerome D., Villano, J Lee, Kozloff, Mark, Wade, James L., Sciortino, David F., Szeto, Livia, Vokes, Everett E.
Published in Journal of thoracic oncology (01.03.2006)

Get full text

Journal Article

P-3 A phase II trial of the combination of temozolomide and irinotecan as second-line therapy for patients with non-small cell lung cancer

P-3 A phase II trial of the combination of temozolomide and irinotecan as second-line therapy for patients with non-small cell lung cancer

by Winegarden, Jerome D., Rudin, Charles M., Mauer, Ann M., Hoffman, Philip, Szeto, Livia, Eileen Dolan, M., Vokes, Everett E.
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2003)

Get full text

Journal Article

P-533 Phase II study of oxaliplatin and paclitaxel in advanced non-small cell lung cancer

P-533 Phase II study of oxaliplatin and paclitaxel in advanced non-small cell lung cancer

by Mauer, Ann M., Otterson, Gregory A., Winegarden, Jerome D., Rudin, Charles M., Villalona, Miguel A., Szeto, Livia, Hoffman, Philip C., Vokes, Everett E.
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2003)

Get full text

Journal Article

A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest

A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest

by GEORGE, Christopher M, HARAF, Dan J, MAUER, Ann M, KRAUSS, Stuart A, HOFFMAN, Philip C, RUDIN, Charles M, SZETO, Livia, VOKES, Everett E
Published in Investigational new drugs (01.01.2001)

Get full text

Journal Article